Factors influencing dropout rate of intermittent preventive treatment of malaria during pregnancyReportar como inadecuado

Factors influencing dropout rate of intermittent preventive treatment of malaria during pregnancy - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Research Notes

, 9:460

Public Health


BackgroundThe burden of malaria in terms of morbidity and mortality is huge is Sub-Saharan Africa, particularly among pregnant women. Among the measures to curb down this burden include intermittent preventive treatment IPT and effective case management. These strategies were adopted by Ghana and implemented since 2003; however, there is still high dropout rate in IPT coverage. This study sought to investigate factors contributing to high dropout rate between IPT1 and IPT3 in the Tamale Metropolis, one of the health facilities with the highest IPT dropout rates in Ghana.

MethodsSurvey, in-depth interviews and short ethnographic techniques were conducted among pregnant women, antenatal care ANC health workers and heads of health facilities to investigate factors which account for dropout rate of intermittent treatment of malaria.

ResultsShortage of sulphadoxine pyrimethamine SP, inadequate supply of portable water for administration of SP, unavailability of IPT during outreach services, lack of knowledge by ANC staff about the dropout rate in their area of jurisdiction and poor attitude of some health workers were identified as barriers to achieving high IPT3 coverage.

ConclusionsLate ANC visit, provider and logistical barriers account for the women’s missed opportunities to prevent malaria in pregnancy through IPT. Addressing the above barriers will contribute to saving lives and ensuring progress towards the goal of combating malaria as well as reducing maternal, neonatal and child mortalities.

KeywordsIntermittent preventive treatment Dropout rate Malaria in pregnancy AbbreviationsANCantenatal care

CWCChild Welfare Clinic

DOTdirect observed therapy

IPTintermittent preventive treatment

PMIPresident’s Malaria Initiative

SPsulphadoxine pyrimethamine

WHOWorld Health Organization

Electronic supplementary materialThe online version of this article doi:10.1186-s13104-016-2265-2 contains supplementary material, which is available to authorized users.

Autor: David Teye Doku - Mumuni Mukaila Zankawah - Addae Boateng Adu-Gyamfi

Fuente: https://link.springer.com/

Documentos relacionados